Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses
- PMID: 11506200
- DOI: 10.1023/a:1010987426835
Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses
Abstract
The present study analyzes the role of CD28-B7-mediated costimulation during in vitro human peripheral blood memory T cell activation by influenza A virus. Inhibition studies using the B7-binding fusion protein CTLA4Ig and antibodies against CD80 and CD86 demonstrate that CTLA4Ig and anti-CD86 inhibited influenza-specific T cell proliferation, interleukin (IL)-2 and interferon (IFN)-gamma production, and generation of influenza-specific CD8+ CTL. The production of IL-10 and IL-18, which are known to modulate T cell immune responses, were not affected by blocking the CD28-B7 costimulatory pathway. Inhibition of diverse influenza-specific T cell functions could be reversed by the addition of exogenous IL-2 or IL-12 but not by the addition of IFN-gamma or IL-18. Although IL-2 is known to overcome CD28-B7 costimulatory requirements, this is the first report showing that exogenous IL-12 is able to bypass CD28-B7 costimulatory blockade induced by CTLA4Ig in vitro. The induction of IFN-gamma production with the recently described IFN-gamma inducing cytokine IL-18 was not detected. In conclusion, these results demonstrate that CD86 represents a major costimulatory signal for the activation of resting peripheral blood memory T cells with recall antigens. These observations may have important implications for the development of immunotherapeutic strategies in diverse immunodeficiency diseases as well as in tumor immunotherapy.
Similar articles
-
Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.Eur J Immunol. 1999 Aug;29(8):2367-75. doi: 10.1002/(SICI)1521-4141(199908)29:08<2367::AID-IMMU2367>3.0.CO;2-3. Eur J Immunol. 1999. PMID: 10458748
-
B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.Int Immunol. 1997 Aug;9(8):1095-102. doi: 10.1093/intimm/9.8.1095. Int Immunol. 1997. PMID: 9263006
-
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.Clin Exp Immunol. 2000 Jan;119(1):19-27. doi: 10.1046/j.1365-2249.2000.01105.x. Clin Exp Immunol. 2000. PMID: 10606960 Free PMC article.
-
CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?Res Immunol. 1995 Mar-Apr;146(3):183-96. doi: 10.1016/0923-2494(96)80256-2. Res Immunol. 1995. PMID: 8525052 Review. No abstract available.
-
Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.Immunol Res. 1995;14(3):176-88. doi: 10.1007/BF02918215. Immunol Res. 1995. PMID: 8778208 Review.
Cited by
-
Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.Aging health. 2008 Dec 1;4(6):603-613. doi: 10.2217/1745509X.4.6.603. Aging health. 2008. PMID: 20011611 Free PMC article.
-
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles.J Immunol Res. 2016;2016:9171632. doi: 10.1155/2016/9171632. Epub 2016 Sep 4. J Immunol Res. 2016. PMID: 27689099 Free PMC article.
-
Reovirus serotypes elicit distinctive patterns of recall immunity in humans.J Virol. 2008 Aug;82(15):7515-23. doi: 10.1128/JVI.00464-08. Epub 2008 May 28. J Virol. 2008. PMID: 18508904 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous